Literature DB >> 21170088

ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin.

J Malapeira1, C Esselens, J J Bech-Serra, F Canals, J Arribas.   

Abstract

The activity of a variety of extracellular signaling factors is tightly regulated by proteins containing A Disintegrin And a Metalloprotease domain (ADAM) metalloproteases through limited proteolysis. Thus, the identification of ADAM substrates may unveil novel components and mechanisms of cell signaling pathways. We report the identification of the transmembrane protein vasorin (VASN), a transforming growth factor-β (TGFβ) trap, as a substrate of ADAM17. The metalloprotease efficiently generates a soluble fragment encompassing the extracellular domain of VASN. Despite the importance of TGFβ in normal development and tumor progression, the regulation of VASN is completely unknown. Here, we show that only the soluble form of VASN inhibits TGFβ and that the secretion of VASN is tightly controlled by ADAM17. Hence, inhibition of ADAM17 leads to the upregulation of TGFβ signaling. Adding a new level of complexity to the function of ADAM17, we finally show that, through the cleavage of VASN, the metalloprotease controls TGFβ-mediated epithelial-to-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170088     DOI: 10.1038/onc.2010.565

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.

Authors:  Gregory G Burrows; Wouter Van't Hof; Laura F Newell; Ashok Reddy; Phillip A Wilmarth; Larry L David; Amy Raber; Annelies Bogaerts; Jef Pinxteren; Robert J Deans; Richard T Maziarz
Journal:  Stem Cells Transl Med       Date:  2013-08-27       Impact factor: 6.940

2.  Global, quantitative and dynamic mapping of protein subcellular localization.

Authors:  Daniel N Itzhak; Stefka Tyanova; Jürgen Cox; Georg Hh Borner
Journal:  Elife       Date:  2016-06-09       Impact factor: 8.140

3.  The unfolded protein response potentiates epithelial-to-mesenchymal transition (EMT) of gastric cancer cells under severe hypoxic conditions.

Authors:  Xinsheng Shen; Yange Xue; Yaqing Si; Qun Wang; Zhao Wang; Jiaxiang Yuan; Xiefu Zhang
Journal:  Med Oncol       Date:  2014-12-14       Impact factor: 3.064

4.  Vasorin contributes to lung injury via FABP4-mediated inflammation.

Authors:  Xiaoping Guo; Junming Sun; Jinning Liang; Siran Zhu; Mingyuan Zhang; Lichao Yang; Xuejing Huang; Kangning Xue; Zhongxiang Mo; Sha Wen; Bing Hu; Jiajuan Liu; Yiqiang Ouyang; Min He
Journal:  Mol Biol Rep       Date:  2022-08-10       Impact factor: 2.742

Review 5.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

6.  Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.

Authors:  Sameer S Bajikar; Chun-Chao Wang; Michael A Borten; Elizabeth J Pereira; Kristen A Atkins; Kevin A Janes
Journal:  Dev Cell       Date:  2017-11-20       Impact factor: 12.270

7.  ADAM17 transactivates EGFR signaling during embryonic eyelid closure.

Authors:  Eryn L Hassemer; Bradley Endres; Joseph A Toonen; Adam Ronchetti; Richard Dubielzig; Duska J Sidjanin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 8.  Targeting Notch in oncology: the path forward.

Authors:  Samarpan Majumder; Judy S Crabtree; Todd E Golde; Lisa M Minter; Barbara A Osborne; Lucio Miele
Journal:  Nat Rev Drug Discov       Date:  2020-12-08       Impact factor: 84.694

9.  The presence of the Y-chromosome, not the absence of the second X-chromosome, alters the mRNA levels stored in the fully grown XY mouse oocyte.

Authors:  Baozeng Xu; Yayoi Obata; Feng Cao; Teruko Taketo
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers.

Authors:  Rimas J Orentas; James J Yang; Xinyu Wen; Jun S Wei; Crystal L Mackall; Javed Khan
Journal:  Front Oncol       Date:  2012-12-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.